PNC FINANCIAL SERVICES GROUP, INC. - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 271 filers reported holding ACCELERON PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$1,188,000
+36.6%
6,911
-0.3%
0.00%0.0%
Q2 2021$870,000
-14.7%
6,934
-7.8%
0.00%0.0%
Q1 2021$1,020,000
+4.2%
7,521
-1.6%
0.00%0.0%
Q4 2020$979,000
+11.0%
7,644
-2.5%
0.00%0.0%
Q3 2020$882,000
+42.7%
7,840
+20.9%
0.00%0.0%
Q2 2020$618,000
+12.2%
6,486
+5.8%
0.00%0.0%
Q1 2020$551,000
+20.3%
6,131
-28.9%
0.00%
Q4 2019$458,000
+46.3%
8,618
+9.3%
0.00%
Q3 2019$313,000
-0.3%
7,886
+3.1%
0.00%
Q2 2019$314,000
-7.4%
7,646
+5.0%
0.00%
Q1 2019$339,000
+5.0%
7,280
-2.2%
0.00%
Q4 2018$323,000
-5.8%
7,440
+24.4%
0.00%
Q3 2018$343,000
+61.0%
5,980
+36.4%
0.00%
Q2 2018$213,000
-95.8%
4,384
-96.7%
0.00%
-100.0%
Q1 2018$5,127,000
+1373.3%
131,119
+1496.7%
0.01%
Q4 2017$348,000
+15.2%
8,212
+1.6%
0.00%
Q3 2017$302,000
+17.1%
8,080
-4.5%
0.00%
Q2 2017$258,000
+81.7%
8,460
+57.8%
0.00%
Q1 2017$142,000
-2.7%
5,360
-6.9%
0.00%
Q4 2016$146,000
-19.8%
5,760
+14.7%
0.00%
Q3 2016$182,000
+5.8%
5,020
-0.7%
0.00%
Q2 2016$172,000
+5633.3%
5,055
+4112.5%
0.00%
Q1 2016$3,000
-50.0%
120
+3.4%
0.00%
Q4 2015$6,000
+100.0%
1160.0%0.00%
Q3 2015$3,000
-25.0%
116
+3.6%
0.00%
Q2 2015$4,000
+100.0%
112
+83.6%
0.00%
Q1 2015$2,000610.00%
Other shareholders
ACCELERON PHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,449,300$59,537,000,0006.61%
Foresite Capital Management II, LLC 188,602$7,748,0004.36%
Foresite Capital Management III, LLC 254,923$10,472,0003.43%
Artal Group S.A. 1,500,000$61,620,0002.49%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,305,174$53,617,0001.93%
Asymmetry Capital Management, L.P. 82,473$3,388,0001.84%
QVT Financial LP 190,977$7,845,0001.66%
SECTORAL ASSET MANAGEMENT INC 269,396$11,067,0001.32%
Sofinnova Investments, Inc. 241,043$9,902,0000.91%
Novo Holdings A/S 119,708$4,918,0000.69%
View complete list of ACCELERON PHARMA INC shareholders